PriceTargets.com logo

Pulse Biosciences - PLSE Stock Price Target and Predictions

  • Consensus Rating: N/A
  • Consensus Price Target: $0.00
  • Forecasted Upside: -100.00%
  • Number of Analysts: 0
  • Breakdown:
  • 0 Sell Ratings
  • 0 Hold Ratings
  • 0 Buy Ratings
  • 0 Strong Buy Ratings
$6.70 As of 04/25/2024 04:29 PM ET
▼ -0.16 (-2.33%)

This chart shows the closing price for PLSE by one month, three months, or twelve months.

Skip Closing Price Chart
1 month | 3 months | 12 months
Get New Pulse Biosciences Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for PLSE and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for PLSE

Analyst Price Target is $0.00
▼ -100.00% Downside Potential
This price target is based on 0 analysts offering 12 month price targets for Pulse Biosciences in the last 3 months. The average price target is $0.00, with a high forecast of $0.00 and a low forecast of $10,000,000.00. The average price target represents a -100.00% upside from the last price of $6.70.

This chart shows the closing price for PLSE for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart




Current Consensus is N/A

The current consensus among 0 contributing investment analysts is to n/a stock in Pulse Biosciences. This N/A consensus rating has held steady for over two years.

Past Monthly Recommendations

Move your mouse over past months for details

Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
11/2/2022
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
1/31/2023
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
5/1/2023
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
7/30/2023
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
10/28/2023
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
1/26/2024
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
3/26/2024
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
4/25/2024

Latest Recommendations

  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
9/21/2022Maxim GroupDowngradeBuy ➝ HoldLow
5/13/2022HC WainwrightDowngradeBuy ➝ NeutralHigh
5/12/2022StephensDowngradeOverweight ➝ Equal WeightHigh
4/1/2022Maxim GroupInitiated CoverageBuy$13.00Medium
4/1/2022StephensLower TargetOverweight$14.00 ➝ $12.00High
4/1/2022HC WainwrightLower TargetBuy$20.00 ➝ $8.50High
2/10/2022HC WainwrightLower TargetBuy$43.00 ➝ $20.00Medium
11/16/2021HC WainwrightLower TargetBuy$46.00 ➝ $43.00High
8/10/2021HC WainwrightReiterated RatingBuy$46.00High
7/26/2021StephensInitiated CoverageOverweight$28.00High
3/11/2021Maxim GroupInitiated CoverageBuy$40.00High
2/4/2021HC WainwrightBoost TargetBuy$40.00 ➝ $46.00High
1/26/2021HC WainwrightBoost TargetBuy$16.00 ➝ $40.00Medium
5/12/2020HC WainwrightUpgradeNeutral ➝ Buy$6.00 ➝ $16.00High
3/17/2020HC WainwrightReiterated RatingHold$6.00High
2/14/2020HC WainwrightDowngradeBuy ➝ Neutral$26.00 ➝ $6.00High
5/1/2019HC WainwrightReiterated RatingBuyLow
(Data available from 4/25/2019 forward)

News Sentiment Rating

0.14 (Hold)

Our news sentiment rating is based on the average sentiment of articles about this company published in the media in the last 30 days of headlines and can range from 2 (very positive sentiment) to -2 (very negative sentiment).

News Sentiment Over Time

Move your mouse over past months for details

Skip to Current Sentiment Summary
  • 4 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
9/28/2023
  • 3 very positive mentions
  • 1 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
10/28/2023
  • 7 very positive mentions
  • 6 positive mentions
  • 2 negative mentions
  • 0 very negative mentions
Mentions as of
11/27/2023
  • 4 very positive mentions
  • 3 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
12/27/2023
  • 1 very positive mentions
  • 0 positive mentions
  • 1 negative mentions
  • 0 very negative mentions
Mentions as of
1/26/2024
  • 5 very positive mentions
  • 2 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
2/25/2024
  • 0 very positive mentions
  • 11 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
3/26/2024
  • 0 very positive mentions
  • 6 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
4/25/2024

Current Sentiment

  • 0 very positive mentions
  • 6 positive mentions
  • 0 negative mentions
  • 0 very negative mentions

Recent Stories by Sentiment

Very Negative

  • No very negative mentions tracked during this time.

Negative

  • No negative mentions tracked during this time.

Positive

Very Positive

  • No very positive mentions tracked during this time.
Pulse Biosciences logo
Pulse Biosciences, Inc. operates as a novel bioelectric medicine company. The company offers CellFX System, a tunable, software-enabled, and console-based platform that delivers nano second duration pulses of electrical energy to non-thermally clear targeted cells while sparing adjacent non-cellular tissue to treat a various medical condition by using its Nano-Pulse Stimulation technology. The company was formerly known as Electroblate, Inc. and changed its name to Pulse Biosciences, Inc. in December 2015. Pulse Biosciences, Inc. was incorporated in 2014 and is headquartered in Hayward, California.
Read More

Today's Range

Now: $6.70
Low: $6.60
High: $6.78

50 Day Range

MA: $8.79
Low: $6.85
High: $10.88

52 Week Range

Now: $6.70
Low: $3.78
High: $13.62

Volume

70,438 shs

Average Volume

180,401 shs

Market Capitalization

$369.97 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.67

Frequently Asked Questions

What sell-side analysts currently cover shares of Pulse Biosciences?

The following equities research analysts have issued reports on Pulse Biosciences in the last year: StockNews.com.
View the latest analyst ratings for PLSE.

What is the current price target for Pulse Biosciences?

0 Wall Street analysts have set twelve-month price targets for Pulse Biosciences in the last year. has the lowest price target set, forecasting a price of $10,000,000.00 for Pulse Biosciences in the next year.
View the latest price targets for PLSE.

What is the current consensus analyst rating for Pulse Biosciences?

Pulse Biosciences currently has from Wall Street analysts. The stock has a consensus analyst rating of "N/A."
View the latest ratings for PLSE.

What other companies compete with Pulse Biosciences?

Other companies that are similar to Pulse Biosciences include Anika Therapeutics, Surmodics, NeuroPace, Beauty Health and SeaSpine. Learn More about companies similar to Pulse Biosciences.

How do I contact Pulse Biosciences' investor relations team?

Pulse Biosciences' physical mailing address is 3957 POINT EDEN WAY, HAYWARD CA, 94545. The company's listed phone number is (510) 906-4600 and its investor relations email address is [email protected]. The official website for Pulse Biosciences is www.pulsebiosciences.com. Learn More about contacing Pulse Biosciences investor relations.